Class II Phosphoinositide 3-Kinases as Novel Drug Targets

© 2016 American Chemical Society. The phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases central to regulating a wide range of important intracellular processes. Despite the vast knowledge around class I PI3Ks, the class II PI3Ks have been neglected, seemingly only due to the chronolo...

Full description

Bibliographic Details
Main Authors: Falasca, Marco, Hamilton, J., Selvadurai, M., Sundaram, K., Adamska, A., Thompson, P.
Format: Journal Article
Published: American Chemical Society 2017
Online Access:http://hdl.handle.net/20.500.11937/63469
_version_ 1848761095771127808
author Falasca, Marco
Hamilton, J.
Selvadurai, M.
Sundaram, K.
Adamska, A.
Thompson, P.
author_facet Falasca, Marco
Hamilton, J.
Selvadurai, M.
Sundaram, K.
Adamska, A.
Thompson, P.
author_sort Falasca, Marco
building Curtin Institutional Repository
collection Online Access
description © 2016 American Chemical Society. The phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases central to regulating a wide range of important intracellular processes. Despite the vast knowledge around class I PI3Ks, the class II PI3Ks have been neglected, seemingly only due to the chronology of their discovery. Here we focus on the cellular functions of the three class II PI3K isoforms, PI3KC2α, PI3KC2β, and PI3KC2γ, in different cell systems and underline the emerging importance of these enzymes in different physiological and pathological contexts. We provide an overview on the current development of class II PI3 kinase inhibitors and outline the potential use for such inhibitors. The field is in its infancy as compared to their class I counterparts. Nevertheless, recent advances in understanding the roles of class II PI3 kinases in different pathological contexts is leading to an increased interest in the development of specific inhibitors that can provide potential novel pharmacological tools.
first_indexed 2025-11-14T10:26:14Z
format Journal Article
id curtin-20.500.11937-63469
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:26:14Z
publishDate 2017
publisher American Chemical Society
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-634692018-02-06T07:40:07Z Class II Phosphoinositide 3-Kinases as Novel Drug Targets Falasca, Marco Hamilton, J. Selvadurai, M. Sundaram, K. Adamska, A. Thompson, P. © 2016 American Chemical Society. The phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases central to regulating a wide range of important intracellular processes. Despite the vast knowledge around class I PI3Ks, the class II PI3Ks have been neglected, seemingly only due to the chronology of their discovery. Here we focus on the cellular functions of the three class II PI3K isoforms, PI3KC2α, PI3KC2β, and PI3KC2γ, in different cell systems and underline the emerging importance of these enzymes in different physiological and pathological contexts. We provide an overview on the current development of class II PI3 kinase inhibitors and outline the potential use for such inhibitors. The field is in its infancy as compared to their class I counterparts. Nevertheless, recent advances in understanding the roles of class II PI3 kinases in different pathological contexts is leading to an increased interest in the development of specific inhibitors that can provide potential novel pharmacological tools. 2017 Journal Article http://hdl.handle.net/20.500.11937/63469 10.1021/acs.jmedchem.6b00963 American Chemical Society restricted
spellingShingle Falasca, Marco
Hamilton, J.
Selvadurai, M.
Sundaram, K.
Adamska, A.
Thompson, P.
Class II Phosphoinositide 3-Kinases as Novel Drug Targets
title Class II Phosphoinositide 3-Kinases as Novel Drug Targets
title_full Class II Phosphoinositide 3-Kinases as Novel Drug Targets
title_fullStr Class II Phosphoinositide 3-Kinases as Novel Drug Targets
title_full_unstemmed Class II Phosphoinositide 3-Kinases as Novel Drug Targets
title_short Class II Phosphoinositide 3-Kinases as Novel Drug Targets
title_sort class ii phosphoinositide 3-kinases as novel drug targets
url http://hdl.handle.net/20.500.11937/63469